Dashboard
Manage Tickers

TLSI


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

oppenheimer-initiates-coverage-on-trisalus-life-sciences-with-outperform-rating-announces-price-target-of-10
Oppenheimer Initiates Coverage On TriSalus...
09/16/2024 11:49:48

Oppenheimer analyst Suraj Kalia initiates coverage on TriSalus Life Sciences (NASDAQ:TLSI) with a Outperform rating and anno...

trisalus-life-sciences-q2-2024-gaap-eps-021-beats-041-estimate-sales-736m-inline
TriSalus Life Sciences Q2 2024 GAAP EPS $(...
08/15/2024 12:02:17

TriSalus Life Sciences (NASDAQ:TLSI) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate o...

canaccord-genuity-maintains-buy-on-trisalus-life-sciences-maintains-12-price-target
Canaccord Genuity Maintains Buy on TriSalu...
06/27/2024 13:44:01

Canaccord Genuity analyst William Plovanic maintains TriSalus Life Sciences (NASDAQ:TLSI) with a Buy and maintains $12 price...

trisalus-life-sciences-presents-liver-and-pancreatic-cancer-data-at-asco-2024
TriSalus Life Sciences Presents Liver and ...
06/03/2024 11:08:24

TriSalus Life Sciences, Inc. (NASDAQ:TLSI), an oncology company integrating its novel Pressure Enabled Drug Delivery™ (PEDD™) t...

canaccord-genuity-initiates-coverage-on-trisalus-life-sciences-with-buy-rating-announces-price-target-of-12
Canaccord Genuity Initiates Coverage On Tr...
05/30/2024 13:00:59

Canaccord Genuity analyst William Plovanic initiates coverage on TriSalus Life Sciences (NASDAQ:TLSI) with a Buy rating and ...

crude-oil-rises-1-verastem-shares-slide
Crude Oil Rises 1%; Verastem Shares Slide
05/24/2024 18:47:50

why-netease-shares-are-trading-lower-here-are-other-stocks-moving-in-fridays-mid-day-session
Why NetEase Shares Are Trading Lower? Here...
05/24/2024 17:57:35

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
05/24/2024 16:31:03

nasdaq-gains-1-intuit-shares-plunge
Nasdaq Gains 1%; Intuit Shares Plunge
05/24/2024 16:07:54

trisalus-life-sciences-q1-2024-gaap-eps-060-beats-065-estimate-sales-6457m-beat-6178m-estimate
TriSalus Life Sciences Q1 2024 GAAP EPS $(...
05/15/2024 12:02:16

TriSalus Life Sciences (NASDAQ:TLSI) reported quarterly losses of $(0.60) per share which beat the analyst consensus estimate o...

jonestrading-initiates-coverage-on-trisalus-life-sciences-with-buy-rating-announces-price-target-of-16
JonesTrading Initiates Coverage On TriSalu...
05/10/2024 18:15:39

JonesTrading analyst Justin Walsh initiates coverage on TriSalus Life Sciences (NASDAQ:TLSI) with a Buy rating and announces...

trisalus-life-sciences-secures-up-to-50m-of-debt-financing-with-orbimed-to-support-trinav-infusion-system-growth-initiatives
TriSalus Life Sciences Secures Up To $50M ...
04/30/2024 21:37:15

$25 million funded at close; up to $25 million of additional capital available at the Company's option, based on the achiev...

trisalus-life-sciences-q4-2023-gaap-eps-156-misses-069-estimate-sales-5721m-beat-5453m-estimate
TriSalus Life Sciences Q4 2023 GAAP EPS $(...
04/01/2024 12:02:54

TriSalus Life Sciences (NASDAQ:TLSI) reported quarterly losses of $(1.56) per share which missed the analyst consensus estimate...

earnings-scheduled-for-april-1-2024
Earnings Scheduled For April 1, 2024
04/01/2024 09:13:21

Companies Reporting Before The Bell • Mach Natural Resources (NYSE:MNR) is projected to report quarterly earnings at $0.92 per...

trisalus-life-sciences-expects-sales-to-grow-in-excess-of-50-in-2024-says-currently-in-the-process-of-obtaining-additional-liquidity-to-fund-operations-through-2024
TriSalus Life Sciences Expects Sales To Gr...
03/11/2024 21:23:04

TriSalus also expects to report cash and cash equivalents balances of approximately $11.8 million as of December 31, 2023. It e...

trisalus-life-sciences-reports-preliminary-q4-sales-of-approximately-57m-representing-77-growth-versus-2022-est-5453m
TriSalus Life Sciences Reports Preliminary...
03/11/2024 21:21:31

For the full year 2023, TriSalus expects to report revenue of approximately $18.5 million. This represents growth of approximat...

trisalus-life-sciences-said-it-received-approval-from-the-world-health-organization-and-the-american-medical-associations-adopted-name-council-for-nelitolimod-as-the-nonproprietary-drug-name-for-sd-101
Trisalus Life Sciences Said It Received Ap...
03/07/2024 12:18:22

trisalus-life-sciences-announced-publication-of-real-world-study-of-trinav-device-for-trans-arterial-chemoembolization-and-trans-arterial-radioembolization-in-patients-with-hepatocellular-carcinoma-and-liver-metastases
TriSalus Life Sciences Announced Publicati...
02/29/2024 12:15:13

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
12/14/2023 17:32:05

trisalus-life-sciences-declares-cms-reimbursement-for-trinav-infusion-system-via-assignment-of-a-new-technology-healthcare-common-procedure-coding-system-hcpcs-code
TriSalus Life Sciences Declares CMS Reimbu...
12/14/2023 12:10:25

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION